Scienture Inc. (SCNX)
Scienture Statistics
Share Statistics
Scienture has 12.52M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 12.52M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 72.33K |
| FTD / Avg. Volume | 2.51% |
Short Selling Information
The latest short interest is 16.82K, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 16.82K |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 2.31 |
Valuation Ratios
The PE ratio is 2.25 and the forward PE ratio is null. Scienture's PEG ratio is -0.02.
| PE Ratio | 2.25 |
| Forward PE | n/a |
| PS Ratio | 149.45 |
| Forward PS | null |
| PB Ratio | 0.26 |
| P/FCF Ratio | -1.43 |
| PEG Ratio | -0.02 |
Enterprise Valuation
Scienture has an Enterprise Value (EV) of 23.65M.
| EV / Sales | 173.04 |
| EV / EBITDA | -1.36 |
| EV / EBIT | -1.66 |
| EV / FCF | -1.66 |
Financial Position
The company has a current ratio of 0.8, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.8 |
| Quick Ratio | 0.8 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.2 |
| Debt / FCF | -0.25 |
| Interest Coverage | -11.01 |
Financial Efficiency
Return on Equity is 11.47% and Return on Invested Capital is -14.32%.
| Return on Equity | 11.47% |
| Return on Assets | 8.65% |
| Return on Invested Capital | -14.32% |
| Revenue Per Employee | $9.76K |
| Profits Per Employee | $647.56K |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -534.4K |
| Effective Tax Rate | 2.85% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 2.72, so Scienture's price volatility has been higher than the market average.
| Beta | 2.72 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 2.1 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 33.14 |
| Average Volume (20 Days) | 2.89M |
Income Statement
In the last 12 months, Scienture had revenue of 136.64K and earned 9.07M in profits. Earnings per share was 2.69.
| Revenue | 136.64K |
| Gross Profit | 6K |
| Operating Income | -14.7M |
| Net Income | 9.07M |
| EBITDA | -17.39M |
| EBIT | -17.44M |
| Earnings Per Share (EPS) | 2.69 |
Balance Sheet
The company has 308.1K in cash and 3.53M in debt, giving a net cash position of -3.22M.
| Cash & Cash Equivalents | 308.1K |
| Total Debt | 3.53M |
| Net Cash | -3.22M |
| Retained Earnings | -39.04M |
| Total Assets | 104.85M |
| Working Capital | -1.6M |
Cash Flow
In the last 12 months, operating cash flow was -14.27M and capital expenditures 0, giving a free cash flow of -14.27M.
| Operating Cash Flow | -14.27M |
| Capital Expenditures | 0 |
| Free Cash Flow | -14.27M |
| FCF Per Share | -4.23 |
Margins
Gross margin is 4.39%, with operating and profit margins of -10758.7% and 6634.66%.
| Gross Margin | 4.39% |
| Operating Margin | -10758.7% |
| Pretax Margin | -13743.02% |
| Profit Margin | 6634.66% |
| EBITDA Margin | -12726.51% |
| EBIT Margin | -10758.7% |
| FCF Margin | -10439.79% |
Dividends & Yields
SCNX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 44.4% |
| FCF Yield | -69.86% |
Analyst Forecast
Currently there are no analyst rating for SCNX.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jun 22, 2023. It was a backward split with a ratio of 1:15.
| Last Split Date | Jun 22, 2023 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -0.92 |
| Piotroski F-Score | 4 |